NCT07725250 Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
| NCT ID | NCT07725250 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Bureau of Economic Research, Inc. |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2026-04-10 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.
Eligibility Criteria
Inclusion Criteria: * Stage I-II hypertension (average clinical readings of blood pressure over 140/90) * Adequate decisional capacity to make a choice about participating in this research study * Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.) Exclusion Criteria: * Pregnancy * Under age 18 years * Institutionalized individuals who are likely to be vulnerable * Dependent on supplemental oxygen
Contact & Investigator
Itzik Fadlon
PRINCIPAL INVESTIGATOR
National Bureau of Economic Research, Inc.
Frequently Asked Questions
Who can join the NCT07725250 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07725250 currently recruiting?
Yes, NCT07725250 is actively recruiting participants. Contact the research team at Alw038@health.ucsd.edu for enrollment information.
Where is the NCT07725250 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT07725250 clinical trial?
NCT07725250 is sponsored by National Bureau of Economic Research, Inc.. The principal investigator is Itzik Fadlon at National Bureau of Economic Research, Inc.. The trial plans to enroll 3,000 participants.